Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/48705
Campo DC Valoridioma
dc.contributor.authorAragón-Sánchez, Javieren_US
dc.contributor.authorHernández-Herrero, Maria J.en_US
dc.contributor.authorLázaro-Martínez, Jose L.en_US
dc.contributor.authorQuintana-Marrero, Yurenaen_US
dc.contributor.authorMaynar-Moliner, Manuelen_US
dc.contributor.authorRabellino, Martínen_US
dc.contributor.authorCabrera-Galván, Juan J.en_US
dc.date.accessioned2018-11-24T00:13:18Z-
dc.date.available2018-11-24T00:13:18Z-
dc.date.issued2010en_US
dc.identifier.issn1534-7346en_US
dc.identifier.urihttp://hdl.handle.net/10553/48705-
dc.description.abstractThe purpose of this study was to analyze the outcomes of major lower extremity amputations (MLEAs) in a series, including diabetic patients, with the aim to study whether diabetes mellitus is a risk factor of in-hospital mortality and perioperative complications. A retrospective analysis of 283 MLEAs (221 of these patients were diabetic and 62 were nondiabetic) performed between January 1, 1998, and December 31, 2008, at the General Surgery Department and Diabetic Foot Unit of La Paloma Hospital in Las Palmas de Gran Canaria (Canary Islands) was done. The significant risk factors of mortality were >75 years of age (odds ratio [OR] = 4.1, 95% confidence interval [CI] = 1.4-11.7), postoperative cardiac complications (OR = 12.3, 95% CI = 3.7-40.2) and postoperative respiratory complications (OR = 3.8, 95% CI = 1.0-13.3). No statistically significant risk factors were found related to the presence of systemic and wound-related complications. In diabetic patients, the significant risk factors of mortality were postoperative cardiological complications (OR = 13.6, 95% CI = 3.1-59.6), postoperative respiratory complications (OR = 5.9, 95% CI = 1.0-35.5), and first episode of amputation (OR = 5.9, 95% CI = 1.4-24.3). There were no statistically significant differences in the outcome of major amputations between diabetic and nondiabetic patients. Hospital stay was significantly longer in diabetic patients (P < .01) though when the patients with diabetic foot infections were excluded, this difference was not found.en_US
dc.languageengen_US
dc.relation.ispartofInternational Journal of Lower Extremity Woundsen_US
dc.sourceInternational Journal of Lower Extremity Wounds[ISSN 1534-7346],v. 9, p. 16-23en_US
dc.subject32 Ciencias médicasen_US
dc.subject3205 Medicina internaen_US
dc.subject.otherLower-Limb Amputationsen_US
dc.subject.otherNondiabetic Patientsen_US
dc.subject.otherGlucose-Intoleranceen_US
dc.subject.otherVascular-Diseaseen_US
dc.subject.otherMellitusen_US
dc.subject.otherPopulationen_US
dc.subject.otherMorbidityen_US
dc.subject.otherCriteriaen_US
dc.subject.otherPrevalenceen_US
dc.subject.otherAdaen_US
dc.titleIn-hospital complications and mortality following major lower extremity amputations in a series of predominantly diabetic patientsen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1177/1534734610361946en_US
dc.identifier.scopus77952467604-
dc.identifier.isi000297297900005-
dc.contributor.authorscopusid6507768519-
dc.contributor.authorscopusid24597529900-
dc.contributor.authorscopusid18434633300-
dc.contributor.authorscopusid24598202200-
dc.contributor.authorscopusid6602289978-
dc.contributor.authorscopusid24537604700-
dc.contributor.authorscopusid6602257053-
dc.description.lastpage23en_US
dc.description.firstpage16en_US
dc.relation.volume9en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.contributor.daisngid693544-
dc.contributor.daisngid3160667-
dc.contributor.daisngid832198-
dc.contributor.daisngid3382562-
dc.contributor.daisngid6698614-
dc.contributor.daisngid1236857-
dc.contributor.daisngid1841045-
dc.description.numberofpages8en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Aragon-Sanchez, J-
dc.contributor.wosstandardWOS:Hernandez-Herrero, MJ-
dc.contributor.wosstandardWOS:Lazaro-Martinez, JL-
dc.contributor.wosstandardWOS:Quintana-Marrero, Y-
dc.contributor.wosstandardWOS:Maynar-Moliner, M-
dc.contributor.wosstandardWOS:Rabellino, M-
dc.contributor.wosstandardWOS:Cabrera-Galvan, JJ-
dc.date.coverdateMarzo 2010en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.scieSCIE-
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptGIR IUIBS: Tecnología Médica y Audiovisual-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptGIR IUIBS: Farmacología Molecular y Traslacional-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.orcid0000-0001-6307-5040-
crisitem.author.orcid0000-0001-9154-0712-
crisitem.author.orcid0000-0002-4184-6403-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameAragón Sanchez,Javier-
crisitem.author.fullNameMaynar Moliner,Manuel-
crisitem.author.fullNameCabrera Galván,Juan José-
Colección:Artículos
Vista resumida

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.